Anthony Bergmann
Director of Finance/CFO at CAPRICOR THERAPEUTICS, INC.
Net worth: 16 167 $ as of 30/03/2024
Anthony Bergmann active positions
Companies | Position | Start | End |
---|---|---|---|
CAPRICOR THERAPEUTICS, INC. | Investor Relations Contact | 19/11/2013 | - |
Director of Finance/CFO | 31/12/2017 | - | |
Comptroller/Controller/Auditor | 19/11/2013 | 31/12/2017 | |
Corporate Officer/Principal | 22/02/2016 | - | |
Treasurer | 21/11/2013 | 21/04/2014 | |
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Director of Finance/CFO | 31/12/2011 | - |
Career history of Anthony Bergmann
Training of Anthony Bergmann
Providence College | Undergraduate Degree |
USC Marshall School of Business | Masters Business Admin |
Statistics
International
United States | 5 |
Operational
Director of Finance/CFO | 2 |
Comptroller/Controller/Auditor | 1 |
Investor Relations Contact | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
CAPRICOR THERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Health Technology |
- Stock Market
- Insiders
- Anthony Bergmann
- Experience